Taiwan FDA registration 2a717107e0ba562e1e59394d5e266964
In vitro test for Corris Legionnaires bacteria (unsterilized)
TW: 科里斯退伍軍人菌體外試驗(未滅菌)
Taiwan·Risk Class 1·CORIS BIOCONCEPT·Registered Sep 24, 2010 – Sep 24, 2020CancelledRegistration details
- Analysis ID
- 2a717107e0ba562e1e59394d5e266964
- Customs Code
- DHA04400925009
Company information
- Manufacturer
- CORIS BIOCONCEPT
- Manufacturer Country
- Belgium
- Authorized Representative
- DYBO ENTERPRISE COMPANY LIMITED
Product details
- Intended Use
- Limit the management method of medical equipment Haemophilus serogenus (C.3300) first level identification range.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3300 嗜血桿菌屬血清試劑
- Import Information
- import
Dates and status
- Registration Date
- Sep 24, 2010
- Expiry Date
- Sep 24, 2020
- Cancellation Date
- May 19, 2022
Cancellation information
- Status
- Logged out
- Reason
- 自行鍵入
About this record
Access comprehensive regulatory information for In vitro test for Corris Legionnaires bacteria (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 2a717107e0ba562e1e59394d5e266964 and manufactured by CORIS BIOCONCEPT. The authorized representative in Taiwan is DYBO ENTERPRISE COMPANY LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices